Epidermolysis Bullosa (EB) Center
First in the world to provide a systemic therapy for EB, we continue to work diligently to find new ways to improve the quality of life for our patients. We collaborate with researchers and research organizations around the world, keeping our program at the forefront of EB care globally.
Current Research Projects
- CelluTome™ non-invasive skin grafting for chronic wounds
- Gene correction of EB-causing gene mutations using gene editing
- Culture expansion of gene-edited skin and bone marrow stem cells
- 3D reconstruction of healthy skin from gene-edited cells of an individual with EB
Contributions to the Field
miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa.
Venturing into the New Science of Nucleases.
Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.
Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa.
From Mesoderm to Mesodermatology: Bone Marrow Mesenchymal Cells Heal Skin Wounds.
Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa.
From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.
Placenta-based therapies for the treatment of epidermolysis bullosa.
The three-body problem of therapy with induced pluripotent stem cells.
A living band-aid for epidermolysis bullosa.
A biologic Velcro patch.
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa.
Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa.
Advances in understanding and treating dystrophic epidermolysis bullosa.
Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa.